LCID, LI, XPEV Stocks Hit 52-Week Lows Today: What's Dragging These EV Firms Lower?

The selloff echoed growing skepticism about whether newer EV manufacturers can sustain growth without continuing to lose money.
Lucid Gravity battery electric mid-size luxury crossover SUV on display during the 2025 Wheels at Mariënwaerdt car show on September 13 in Beesd, The Netherlands.
Lucid Gravity battery electric mid-size luxury crossover SUV on display during the 2025 Wheels at Mariënwaerdt car show on September 13 in Beesd, The Netherlands. (Photo by Sjoerd van der Wal/Getty Images)
Profile Image
Shivani Kumaresan·Stocktwits
Published May 20, 2026   |   11:26 PM EDT
Share
·
Add us onAdd us on Google
Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...Loading...
  • Lucid shares faced pressure after the company said it was suspending its 2026 production forecast earlier this month. 
  • Li Auto’s aggressive discounts have raised concerns about margins. 
  • XPeng shares fell to a fresh 52-week low of $14.72 ahead of its May 28 earnings report. 

Lucid Group (LCID), Li Auto (LI) and XPeng (XPEV) stocks dropped to fresh 52-week lows on Wednesday as investors intensified concerns about profitability, pricing pressure, and rising operating costs across the electric vehicle sector. 

While Lucid and XPeng stocks pared losses to close Wednesday’s trading session over 1% higher each, Li Auto finished the day flat. 

Read Next
Loading...
Loading...

LCID Faces Mounting Financial Pressure

Lucid shares fell to a year-low of $5.56 amid weakness surrounding its production outlook for full-year 2026, which is on pause. The luxury EV maker had previously expected annual production between 25,000 and 27,000 vehicles.

In its Q1 results earlier this month, the company said that although its sales improved year-on-year, it still recorded a quarterly net loss of roughly $1 billion. Last week, Citi lowered its price target on the EV maker to $14 from $17. 

The company is now relying more on its long-term self-driving-vehicle partnerships with Uber Technologies (UBER) and Nuro. Lucid plans to help launch a fleet of 35,000 robotaxis starting in late 2026, moving its focus from luxury car buyers to commercial transportation services. 

On Stocktwits, retail sentiment around the stock remained in ‘bearish’ territory. 

LI’s Struggles With Competition 

Li Auto, once viewed as one of the stronger premium EV players in China, has increasingly faced competition from domestic rivals, including BYD Co.

The company introduced last week refreshed versions of its L9 SUV lineup, featuring new artificial intelligence capabilities and upgraded software features. However, the launch failed to impress investors after Li Auto offered aggressive pricing incentives to attract buyers. 

Also, the company delivered 34,085 vehicles in April, a 17% decline from March. Retail sentiment on the stock shifted to ‘neutral’ from ‘bearish’. 

XPEV Awaits Q1 Report 

XPeng shares fell to a new 52-week low of $14.72 ahead of its first-quarter earnings report due on May 28. The company delivered more than 62,000 vehicles during the quarter, meeting its target, but still deliveries dropped 47% compared with Q4 2025.

Aggressive discounting across China’s EV industry could weigh further on profitability. 

XPeng continues to push aggressively into autonomous driving and AI technologies. The company’s plan to spend roughly RMB 7 billion on research into advanced driver-assistance systems, robotics, and proprietary AI chips has investors worried about the near-term financial burden of heavy development costs.

However, retail sentiment around the stock jumped to ‘bullish’ from ‘bearish’ territory. 

So far this year, LCID and XPEV stocks have lost over 46% and 25%, respectively, while LI stock has dropped by 4%.

Also See: Why Is ASPI Stock Extending Gains Overnight Today?

For updates and corrections, email newsroom[at]stocktwits[dot]com.

Follow on Google News
Read about our editorial guidelines and ethics policy